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Interferon gamma (IFN-γ) plays an important role in the antiviral immune response dur-
ing respiratory syncytial virus (RSV) infections. Monocytes and T cells are recruited to
the site of RSV infection, but it is unclear whether cell-cell interactions between mono-
cytes and T cells regulate IFN-γ production. In this study, micro-array data identified
the upregulation of sialic acid-binding immunoglobulin-type lectin 1 (Siglec-1) in human
RSV-infected infants. In vitro, RSV increased expression of Siglec-1 on healthy newborn
and adult monocytes. RSV-induced Siglec-1 on monocytes inhibited IFN-γ production by
adult CD4+ T cells. In contrast, IFN-γ production by RSV in newborns was not affected by
Siglec-1. The ligand for Siglec-1, CD43, is highly expressed on adult CD4+ T cells com-
pared to newborns. Our data show that Siglec-1 reduces IFN-γ release by adult T cells
possibly by binding to the highly expressed CD43. The Siglec-1-dependent inhibition of
IFN-γ in adults and the low expression of CD43 on newborn T cells provides a better
understanding of the immune response against RSV in early life and adulthood.
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Introduction
Respiratory syncytial virus (RSV) is a major cause of respiratory
disease worldwide. Nearly all infants have been infected by RSV
by the age of 2 years. Infants and adults remain susceptible every
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year to RSV infections with genetically related viruses or identi-
cal virus strains [1]. The high rate of reinfections by RSV results
in a significant burden on health care in infants and elderly [2].
Interferon gamma (IFN-γ) and T cells are essential to mount an
adequate immune response during RSV infections in newborn and
adult mice [3–5]. This suggests an important role for IFN-γ in the
clearance of primary infections as well as in reinfections [4, 6].
Inhibition or inadequate activation of T cells resulting in lower
secretion of IFN-γmay explain this high rate of reinfections [7, 8].
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Monocytes and T cells are both recruited to the site of RSV infec-
tion and the role of monocytes in the pathogenesis of RSV infec-
tions has been appreciated for decades [9–15]. RSV increases the
expression of major histocompatibility complex (MHC) molecules
on monocytes, activates CD4+ T cells and induces the produc-
tion of IFN-γ by human immune cells In vitro [15]. It is unknown
whether monocytes exert a regulatory role on effector T cell func-
tion via cell-cell interaction and thus regulate the production of
IFN-γ. In this study, we used an unbiased approach to select
membrane-bound receptors on monocytes that are induced during
RSV infection in infants and could play a role in cell-cell interac-
tions with T cells. We selected acid-binding immunoglobulin-type
lectin 1 (Siglec-1) and monitored the induction of Siglec-1 on
monocytes after exposure of newborn and adult immune cells to
RSV In vitro. In addition, we determined the role of Siglec-1 dur-
ing RSV-induced release of IFN-γ by T cells in newborns and adults
and investigated the expression of CD43, as the natural ligand for
Siglec-1, on newborn and adult T cells.
Results
Induction of Siglec-1 expression during RSV infection
We first compared whole blood gene expression levels from RSV-
infected infants with healthy infants to select genes that are upreg-
ulated during RSV infection in vivo. Fifteen genes were upregu-
lated during in vivo RSV infection using a cut-off value of 4-fold
difference (Table 1). We next compared In vitro gene expression
levels of unstimulated adult PBMCs versus RSV-stimulated adult
PBMCs. More than four hundred genes were upregulated in adult
PBMCs during In vitro RSV infection using a cut-off value of 4-
fold difference (Fig. 1A). Seven genes were upregulated in both
the analysis derived from RSV-infected infants and the analysis
derived from RSV-stimulated PBMCs: C19ORF59, IFI27, IFI44L,
IFI1, IFI6, OASL, RSAD2 and SIGLEC1 (Table 1; Fig. 1B). Via this
approach, we combined transcriptome analyses from RSV-infected
infants with In vitro RSV-stimulated adult PBMCs and identified
potential genes that could be involved in the cell–cell interaction
between monocytes and T cells. SIGLEC1 was the only gene that
has been implicated in direct cell-cell contact with T cells [16] and
was therefore selected as our gene of interest for further investi-
gation. We observed a correlation between the RSV titer in the
nasopharyngeal aspirate of RSV-infected infants and expression
of Siglec-1 (Fig. 1C). The expression of Siglec-1 was higher in
infants during the acute phase of infection compared to infants in
the recovery phase, which suggests a temporal induction of Siglec-
1 during RSV infection (Fig. 1D). Eight children provided a blood
sample during the acute phase and the recovery phase. From these
eight individuals, paired analysis showed a reduction of Siglec-1
expression in all cases (data not shown).
RSV induces Siglec-1 on monocytes
We employed newborn CBMCs and adult PBMCs to investigate the
induction of Siglec-1 by RSV In vitro. We observed an increase of
Siglec-1+ cells only in the CD14+ fraction that consists of mono-
cytes (Fig. 2A, representative figure). The RSV-induced increase
of Siglec-1+ monocytes was observed in newborn and adult
(Fig. 2B). Only a small percentage of newborn and adult CD14−
cells expressed Siglec-1 which did not increase after exposure to
RSV (Fig. 2A, representative figure). The increase in frequency
of Siglec-1 positive monocytes when stimulating purified adult
monocytes with RSV suggests a direct effect of RSV on mono-
cytes (Fig. 2C). In addition, we showed that RSV increased the
Table 1. Upregulation of gene expression in whole blood from RSV-infected infants. Median gene expression levels in whole blood from
RSV-infected infants (N = 40) (row 1) and healthy controls (N = 14) (row 2) are depicted. Difference in gene expression was calculated as followed:
(median gene expression level RSV-infected infants) – (median gene expression level healthy controls) (row 3). Differences in gene expression
were log2-transformed and genes with  4-fold difference between RSV-infected infants and healthy controls are depicted (row 4)
Gene Median expression level
RSV-infected infants (N = 40)
Median expression level
healthy controls (N = 14)
Difference expression level
(RSV versus healthy)
Log2 transformed difference
in expression level
IFI27 12.03 6.71 5.3 39.4
CD177 10.90 7.39 3.5 11.3
LTF 10.75 7.98 2.8 7.0
OLFM4 8.87 6.03 2.8 7.0
MMP8 8.81 6.22 2.6 6.1
RSAD2 11.69 9.23 2.5 5.7
SIGLEC1 9.68 7.28 2.4 5.3
IFI44L 11.56 9.20 2.4 5.3
ARG1 9.64 7.38 2.3 4.9
CEACAM8 9.01 6.70 2.3 4.9
C19ORF59 11.51 9.32 2.2 4.6
RSAD2 10.93 8.73 2.2 4.6
DEFA4 9.55 7.48 2.1 4.3
IFI6 11.86 9.82 2.0 4.0
IFIT1 11.94 9.91 2.0 4.0
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Figure 1. Induction of Siglec-1 expression during RSV infection. (A) Transcriptome analysis of unstimulated adult PBMCs (N = 5) (x-axis) compared
to RSV-stimulated adult PBMCs (N = 5) stimulated with RSV for 24 h (y-axis). Plots in the upper left corner represent genes that are upregulated
during In vitro RSV infection of adult PBMCs. A difference of ± 4-fold difference between expression levels of unstimulated compared to expression
levels of RSV-stimulated PBMCs was used to determine up- and downregulation of genes. Data shown are pooled from two or more independent
experiments with two or three samples per experiment (B) Transcriptome analysis of unstimulated adult PBMCs (x-axis) compared to RSV-
stimulated adult PBMCs (y-axis) combined with upregulated genes in whole blood from RSV-infected infants in Table 1 (white dots). (C) Correlation
of Siglec-1 gene expression (y-axis) and RSV titers in the nasopharyngeal aspirate (x-axis) during infant RSV infection. (D) Comparison of Siglec-1
gene expression level in healthy infants (Healthy; N = 14), RSV-infected infants (Acute; N = 40) and infants 4–6 weeks after RSV infection (Recovery;
N = 30). Data points depicted represent individual samples from two or more independent experiments with ten to fifteen samples per experiment
Data are represented as median ± interquartile range. Statistical analysis employed Kruskal-Wallis test and if significant followed by Mann–
Whitney U test. Spearman correlation test was used for correlation tests. Dashed lines indicate a 4-fold difference of expression level between
x-axis and y-axis. **p<0.01. ***p<0.001.
quantitative expression of Siglec-1 on newborn and adult CD14+
monocytes determined by mean fluorescence intensity (Fig. 2D).
RSV-induced IFN-γ is delayed in newborns and
dependent on CD4+ T cells
During RSV infection, IFN-γ is an important cytokine that can be
produced by T cells. Newborn CBMCs are na¨ıve and devoid of
RSV-specific memory T cells whereas adults contain RSV-specific
memory T cells [17]. Significant amounts of IFN-γ were mea-
sured in the supernatant of adult MCs two days after exposure
to RSV, whereas IFN-γ was not detectable in supernatants from
newborn MCs (Fig. 3A). However, RSV induced IFN-γ release by
newborn MCs after an incubation period of 5 days was compa-
rable to the induction of IFN-γ in adults after 5 days (Fig. 3B).
Mononuclear cells were depleted from CD4+, CD8+ and CD56+
cells to discern which cells within the MC fraction produced
IFN-γ in response to RSV (Fig. 3C). Depletion of CD4+ cells
reduced the RSV-mediated production of IFN-γ in cultures of both
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Figure 2. RSV induces Siglec-1 on monocytes. (A): Representative gating strategy to determine Siglec-1 expression on monocytes (CD14+ cells)
after stimulation of MCs with RSV. (B-C): Percentage of Siglec-1+ monocytes after stimulation of (B) MCs or (C) adult monocytes with RSV N = 5-7.
(D): Mean fluorescence intensity of Siglec-1 on CD14− and CD14+ cells after stimulation of MCs with RSV (N = 5). Data represent means ± SEM.
Statistical analyses employed theWilcoxonmatched-pairs signed rank test. *p<0.05. **p<0.01. Data are pooled from two or more experiments with
two to four samples per experiment.
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Figure 3. RSV-induced IFN-γ is delayed in newborns and dependent on CD4+ T cells. (A-B): Production of IFN-γ (measured by ELISA performed in
duplo) by CBMCs and PBMCs after stimulation with RSV for (A) 48 h or (B) 5 days. N = 5. Data are pooled from two or more experiments with two to
four samples per experiment. (C): Representative flow cytometry results of MCs after depletion of CD4+, CD8+ or CD56+ cells. (D-E: RSV-induced
IFN-γ release, measured by ELISA performed in duplo, by (D) CBMCs, CD4-depleted CBMCs, CD8-depleted CBMCs or CD56-depleted CBMCs after
5 days and (E) RSV-induced IFN-γ release by PBMCs, CD4-depleted PBMCs, CD8-depleted PBMCs or CD56-depleted PBMCs after 48 h. N = 5. Data
are pooled from two or more experiments with two to four samples per experiment. Data represent means ± SEM. Statistical analysis employed
Wilcoxon matched-pairs signed rank test for two conditions and repeated measures ANOVA with Bonferroni’s Multiple Comparison Test for more
than two conditions. Comparative testing between newborns and adults was performed with Mann–Whitney U test. *p<0.05.
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newborn and adult MCs (Fig. 3D). No reduction of RSV-induced
IFN-γ release was observed after depletion of CD8+ cells and
CD56+ cells (Fig. 3D).
RSV-induced Siglec-1 inhibits IFN-γ release by adult
T cells but not by T cells from newborns
Siglec-1 is the only siglec without a signaling motifs which sug-
gests a mode of action via cell-cell interaction [18]. To investigate
cell-cell interactions betweenmonocytes and T cells, we usedmon-
oclonal blocking antibodies against Siglec-1 to determine the effect
of Siglec-1 on the release of IFN-γ by CD4+ T cells. Exposure of
MCs to the blocking antibodies alone did not induce IFN-γ in new-
borns or adults (data not shown). Blocking Siglec-1 did not affect
the percentage of RSV-infected adult monocytes or the amount of
replication in adult monocytes as depicted by mean fluorescence
intensity (Fig. 4A–B). Blocking of Siglec-1 did not affect RSV-
induced IFN-γ release by T cells from newborn MCs (Fig. 4C), but,
in contrast to newborns, blocking Siglec-1 significantly increases
the RSV-induced IFN-γ release by adult MCs (Fig. 4D). To deter-
mine whether the inhibitory effect of Siglec-1 in adult PBMCs was
due to the presence of memory CD4+ T cells, adult PBMCs were
depleted from memory CD4+ T cells. Depletion of memory CD4+
T cells reduced the production of RSV-induced IFN-γ by adults
(Fig. 4E), Blocking Siglec-1 no longer affected RSV-induced IFN-γ
release by adult T cells when PBMCs are depleted of memory CD4+
T cells (Fig. 4F).
Low CD43 expression on newborn and adult naı¨ve
CD4+ T cells
Our data showed that despite comparable induction of Siglec-1
expression in newborn and adult monocytes, Siglec-1 inhibited
IFN-γ by adult T cells in the presence of memory CD4+ T cells.
Siglec-1 is a sialic-acid binding receptor and CD43 is a highly sialy-
lated receptor on T cells that acts as a natural ligand for Siglec-1.
We hypothesized that CD43 may be differentially expressed on
newborn,, adult na¨ıve and adultmemory T cells that would explain
the inhibitory effect of Siglec-1 only when adult memory CD4+
T cells are present. The expression of CD43 was higher on adult
CD4+ T cells compared to newborns (Fig. 5A–B). Additionally, we
investigated the expression of CD43 on the major subsets of CD4+
T cells, being na¨ıve, central memory, effector memory and ter-
minally differentiated CD4+ T cells (Fig. 5A). Adult CD4+ T cells
consisted of all the measured subsets of CD4+ T cells, whereas,
as expected, newborn effector memory (average of 0.019%) and
terminally differentiated CD4+ T cells (average of 0.006%) were
barely detected (Fig. 5A). CD43 expression on newborn na¨ıve and
newborn central memory CD4+ T cells was significantly lower
compared to adults (Fig. 5C). Adult effector memory and termi-
nally differentiated CD4+ T cells contained a higher expression of
CD43 compared to adult na¨ıve CD4+ T cells (Fig. 5D).
Discussion
We demonstrate for the first time that (a) Siglec-1 is upregulated
after RSV infections in vivo and In vitro on newborn and adult
monocytes, (b) the RSV-induced production of IFN-γ is depen-
dent on CD4+ T cells in both adults and newborns but delayed in
newborns, and (c) Siglec-1 inhibits the RSV-induced IFN-γ release
by adult T cells whereas the production of IFN-γ by newborn T cells
is not affected by Siglec-1. Finally, we show that (d) the expres-
sion of CD43, the natural ligand for Siglec-1, is lower on newborn
CD4+ T cells compared to adult CD4+ T cells.
In this study, a micro-array data base was used to identify
Siglec-1 as a clinically relevant monocytes receptor. Our microar-
ray data also showed that a considerable number of genes are
downregulated in adult PBMCs following RSV exposure. However,
none of these genes were significantly downregulated in vivo in
whole blood from RSV-infected infants (data not shown). Upregu-
lation of Siglec-1 on monocytes has been observed in patients with
atherosclerosis, systemic sclerosis, rheumatoid arthritis, systemic
lupus erythematous and human immunodeficiency virus infec-
tions [19–23]. The common denominator in these studies appears
to be type I interferons (IFNs). Our study showed an upregulation
of multiple interferon regulated genes in whole blood from infants
with RSV infection indicating that the induction of Siglec-1 during
RSV infection could be dependent on type I IFNs. Human experi-
mental RSV infection models in adults have been performed [24]
and could be used to confirm our results derived fromRSV-infected
infants. Whole blood gene expression may not accurately reflect
the inflammatory response at the site of infection but rather reflect
inflammation in general. Therefore, we determined the In vitro
expression of Siglec-1 on monocytes after exposure of PBMCs to
RSV directly. In addition, we measured the expression of Siglec-1
after exposure of PBMCs to lipopolysaccharide (LPS), a bacterial
ligand, and we observed no increase of Siglec-1 expression after
exposure to LPS (data not shown). These data are in line with
previous literature [19] and suggest that the induction of Siglec-1
on monocytes may be interferon- or viral-specific rather than an
induction due to inflammation in general. We decided to use adult
PBMCs to evaluate the upregulation of Siglec-1 in adults, because
this model would allow us to compare mononuclear cells form
newborns and adults In vitro and investigate Siglec-1-dependent
immune signaling. The comparable RSV-induced expression of
Siglec-1 on newborn and adult monocytes suggests a viral-induced
pathway that is already functional at birth. RSV-induced expres-
sion of Siglec-1 may be present on recruited monocytes and/or
resident macrophages to regulate T cell functionality at the site of
infection [9].
The functionality of Siglec-1 during viral infection differs
between viruses. Siglec-1 has been implicated in cell entry of
human immunodeficiency virus (HIV). Sialoglycans are present
on the gp120 envelope of HIV and mediate cell entry via Siglec-1.
Little is known about cellular receptors for RSV and nucleolin has
been proposed as an important receptor for RSV fusion protein
to allow cell entry of epithelial cells [25]. Our data indicate that
Siglec-1 is not required for RSV infection of monocytes.
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Figure 4. RSV-induced Siglec-1 inhibits IFN-γ release by adult T cells but not by T cells from newborns. A–B: (A) Percentage of RSV+ monocytes
and (B) GFP fluorescence (MFI) of monocytes after stimulation of adult MCs with RSV in the absence (No blocking) or presence of monoclonal
antibodies against Siglec-1 (Anti-Siglec-1) or in the presence of matching isotype controls (Isotype). Data were obtained by flow cytometry. N = 5.
Data are pooled from two or more experiments with two to four samples per experiment. (C and D): RSV-induced IFN-γ release by (C) newborn
CBMCs after 5 days or (D) adult PBMCs after 48h in the absence (No blocking) or presence of monoclonal antibodies against Siglec-1 (anti-Siglec-1)
or in the presence of matching isotype controls (Isotype). N = 4–6. Data are pooled from two or more experiments with two to four samples per
experiment performed in duplo. (E:) Percentage of RSV-induced IFN-γ by PBMCs or PBMCs depleted frommemory CD4+ T cells. RSV-induced IFN-γ
by PBMCS was set to 100. N = 5. Data are pooled from two or more experiments experiments with two to four samples per experiment performed
in duplo. (F): RSV-induced IFN-γ release by adult PBMCs depleted from memory CD4+ T cells after 48h in the absence (No blocking) or presence
of monoclonal antibodies against Siglec-1 (anti-Siglec-1) or in the presence of matching isotype controls (Isotype). N = 5. Data are pooled from
two or more experiments experiments with two to four samples per experiment performed in duplo. Data represent means ± SEM. Statistical
analyses employed the Wilcoxon matched-pairs signed rank test for paired analysis between two conditions and repeated measures ANOVA with
Bonferroni’s Multiple Comparison Test for paired analysis between more than two conditions. *p<0.05. ***p<0.001.
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Figure 5. Low CD43 expression on newborn CD4+ T cells compared to adults. (A) Representative gating strategy to measure CD43 expression
on naı¨ve (CD3+CD4+CD45RA+CD27+), central memory (CD3+CD4+CD45RA−CD27+), effector memory (CD3+CD4+CD45RA−CD27−) and terminally
differentiated (CD3+CD4+CD45RA+CD27−) CD4+ T cells. (B) Expression of CD43 on newborn and adult CD4+ T cells. (C) CD43 expression on naı¨ve
and central memory CD4+ T cells in newborns and adults. N = 5–6. D: Expression of CD43 on adult naı¨ve, central memory, effector memory and
terminally differentiated CD4+ T cells. Data are pooled from two or more experiments with two to four samples per experiment. Data represent
means ± SEM. Statistical analysis employed Repeated measures ANOVA with Bonferroni’s Multiple Comparison Test for paired analysis between
more than two conditions. Comparative testing between newborns and adults was performed with Mann–Whitney U test. *p: <0.05. **p<0.01;
***p<0.001.
In general, newborn CD4+ T cells produce low amounts of
IFN-γ compared to adults [26]. We show that newborn CD4+
T cells are capable of producing comparable levels of IFN-γ com-
pared to adults but in a delayed fashion compared to adults. The
formation of IFN-γ-producing cells upon RSV infection in new-
born mice is also delayed and may underlie the susceptibility
of young infants to severe RSV infections in vivo [3]. We pro-
pose that RSV-specific IFN-γ-producing memory T cells in adults
rapidly produce IFN-γ In vitro, whereas IFN-γ production by new-
born na¨ıve T cells newborns is delayed. In our assay, deple-
tion of CD4+ T cells reduced the production of IFN-γ by CBMC
and PBMC upon exposure to RSV, whereas depletion of CD8+
T cells did not. Because our model does not include epithe-
lial cells and lung-residential immune cells, CD8+ T cells may
still contribute to the production of IFN-γ during RSV infec-
tions in vivo. In addition, depletion of memory CD4+ T cells
reduced the production of IFN-γ in adults. The remaining induc-
tion of IFN-γ may be due to incomplete depletion of memory
CD4+ T cell as flow cytometry showed approximately 70–80%
reduction in memory CD4+ T cells (data not shown). Alterna-
tively, na¨ıve T cells could also be responsible for the induction of
IFN-γ.
This study shows a distinct inhibitory effect of Siglec-1 on the
release of IFN-γ by adult CD4+ T cells in contrast to newborns.
The expression of Siglec-1 is comparable between newborn and
adult monocytes. The expression of Siglec-1 can, therefore, not
explain the differences in Siglec-1-dependent signaling between
newborns and adult T cells. Siglec-1 is the only siglec without a
signaling motifs which suggests a mode of action via cell-cell inter-
action [18]. A major difference between newborn and adult T cells
is the high percentage of memory CD4+ T cells in adult PBMCs.
Our data indicate that the presence of memory CD4+ T cells is
required for Siglec-1 to have an inhibitory effect on RSV-induced
IFN-γ release. CD43 is a highly sialylated receptor on T cells and
has been identified as the major receptor for Siglec-1 [27]. T cells
from mice lacking CD43 are able to bind Siglec-1, which suggests
that in mice another receptor may also be involved [28]. How-
ever, in humans only human CD43 has been proposed as the main
receptor for Siglec-1 [27]. We show that the expression of CD43
is lower on newborn na¨ıve CD4+ T cells compared to adult na¨ıve
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CD4+ T cells. In addition, we show a high expression of CD43 on
adult differentiated T cells such as effector memory T cells and
terminally differentiated T cells compared to adult na¨ıve CD4+
T cells. Cross-linking of CD43 is important for proper cytokine
production [29] and Siglec-1 may prevent this process. We
hypothesize that newborn and adult na¨ıve T cells produce IFN-γ
in response to RSV but their low expression of CD43 may prevent
the inhibitory binding of Siglec-1. Contrary, adult memory T cells
have a high expression of CD43 that allows Siglec-1 to exert an
inhibitory effect on the release of IFN-γ. The use of primary human
cells and the absence of a commercially available CD43 blocking
antibody warrants the use of other models, such as mouse models,
for future research to demonstrate that Siglec-1 directly inhibits
the production of IFN-γ during RSV infection through CD43. Clin-
ically, these data suggest that the inhibitory effect of Siglec-1 on
T cells mainly affects memory T cells during reinfections. Mejias
et al also observed an inhibitory effect of RSV on T cells during
RSV infections in infants [30]. Future research should determine
at what time after birth this inhibitory effect takes place, because
our data indicate that in certain circumstances Siglec-1-dependent
inhibition of T cells is not present directly after birth.
CD43 can bind other receptors than Siglec-1 such as MHC-I
[31]. The low expression of CD43 on newborn CD4+ T cells
and the inhibitory role of Siglec-1 in adults could therefore have
multiple implications on T cells during infectious diseases. The
inhibitory effect of monocytes on T cells via Siglec-1 may apply
to other antigen-presenting cells such as dendritic cells (DCs)
and macrophages. During In vitro human rhino virus infections,
DCs inhibit T cells via Siglec-1 [16, 21, 32]. Future research
to investigate the cell-cell interaction between monocytes, DCs,
macrophages and T cells would enhance our understanding of the
regulatory role of antigen-presenting cells during RSV infection.
In vivo, Siglec-1-deficient mice have an enhanced T cell response
to exosomal antigens indicating an inhibitory Siglec-1-dependent
pathway in mice [33]. Infection of Siglec-1-deficient mice with
RSV may give more insight into the role of Siglec-1 during RSV
infection in vivo.
In conclusion, this study identified a regulatory pathway during
RSV infection that involves Siglec-1, monocytes and T cells. Our
data show a delayed kinetic of RSV-induced IFN-γ by newborn
CD4+ T cells compared to adult CD4+ T cells and an inhibitory role
of Siglec-1 on the production of IFN-γ in adults. Insights into the
distinct Siglec-1-dependent inhibition of IFN-γ by RSV in adults
compared to newborns and the low expression of CD43 in new-
borns will provide a better understanding of the antiviral immune
response against RSV directly after birth compared to adults.
Materials and methods
Transcriptome analysis of whole blood from
RSV-infected infants and RSV-stimulated PBMCs
Our group has published whole blood gene expression of RSV-
infected infants and healthy control infants. The methods are
described by Jong et al. [34] and the microarray data was
deposited in the ArrayExpress database under the access number
E-MTAB-5195. I`n addition, we previously published a microarray
database regarding PBMCs from healthy adults that are untreated
or stimulated with RSV. The methods have been described by our
group previously [35] and this microarray data has been deposited
in the NCBI Gene Expression Omnibus (GEO) database under GEO
Series accession number (GSE59391) [35]. We combined these
two microarray databases for the current study. To first select
clinically relevant genes, we used a cut-off value of 4-fold dif-
ference between RSV-infected infants and healthy controls in the
whole blood transcriptome analyses. A similar cut-off value of
4-fold difference was used for the microarray data published by
Vissers et al. [35] to identify genes that are upregulated In vitro
upon exposure of adult PBMCs to RSV. We then determined which
genes were upregulated in both microarray analyses, being upreg-
ulated genes derived from whole blood from RSV-infected infants
and upregulated genes derived from In vitro RSV-stimulated adult
PBMCs, to identify clinically relevant genes that could be inves-
tigated in our model of PBMCs. Written informed consent was
obtained from all donors or from all parents of patients. The study
was approved by the Regional Committee on Research involving
Human Subjects Arnhem-Nijmegen.
Virus culture
Green fluorescent protein (GFP)-labeled RSV A2 (rgRSV30),
kindly provided by Dr. M.E. Peeples, was cultured as previously
described [35].
Cell isolation and stimulation
Human newborn cord blood was collected from the umbili-
cal cord after Cesarean section. Premature births and births to
HIV-positive mothers were excluded. Peripheral blood was col-
lected from healthy adult volunteers. Experimental guidelines
of the Regional Committee on Research involving Human Sub-
jects Arnhem-Nijmegen were observed. Newborn or adult blood
was layered onto Ficoll-Hypaque (GE Healthcare) to collect cord
blood mononuclear cells (CBMCs) and peripheral blood mononu-
clear cells (PBMCs), respectively. When indicated, monocytes
were purified via negative selection (Monocyte Isolation Kit II
human; Miltenyi Biotec). CD4+ T cells, memory CD4+ T cells,
CD8+ T cells or CD56+ natural killer (NK) cells were depleted
from the mononuclear (MC) fraction using specific microbeads
(Miltenyi Biotec), according to the manufacturer’s instructions.
MCs or monocytes were incubated at 5 × 105 or 1 × 105 cells/well
respectively and incubated with RSV at an MOI 1 at 370C and 5%
C02 for 48h or 5 days. When indicated, MCs were pre-treated with
anti-Siglec-1 monoclonal antibodies (HSn 7D2, ab18619; Abcam)
for 1h at 370C. Blocking experiments were performed with match-
ing isotype controls (mouse IgG1 Isotype, eBioscience).
C© 2017 The Authors. European Journal of Immunology published by
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Flow cytometry
To analyse expression of surface markers, MCs were incubated
with fluorochrome-labeled monoclonal antibodies for 30 min in
the dark on ice and fluorescence intensity was measured using
a LSR II flow cytometer (BD Biosciences). CD3 V500, CD3 Alexa
Fluor 647, CD4 PerCP-Cy5.5, CD8 APC-H7, CD14 V500, CD14 Pe-
Cy7, CD27 BV510, CD43 FITC, CD45RA PeCy-7, CD56 BV510 (BD
Biosciences) and Siglec-1 Alexa Fluor 647 (Sanbio)were used. Rel-
ative mean intensity fluorescence (MFI) of CD43 was calculated as
follows: MFI stained/MFI unstained. GFP fluorescence was used
to determine replication of (GFP)-labeled RSV.
Cytokine release
IFN-γ concentrations were measured in culture supernatants by
enzyme-linked immunosorbent assay (ELISA) according to the
manufacturer’s instructions (Sanquin, Amsterdam, The Nether-
lands). The detection limit was 19 pg/mL. All conditions were
measured in duplicate.
Statistical analysis
Statistical analyses employed the Wilcoxon matched-pairs signed
rank test for paired analysis between two conditions and repeated
measures ANOVA with Bonferroni’s Multiple Comparison Test
for paired analysis between more than two conditions. Compar-
ison between newborns and adults employed Mann–Whitney U
test. Comparison between more than two groups employed the
Kruskal–Wallis test followed by Dunn’s Multiple Comparison Test.
Tests were considered significant if p<0.05. All statistical analyses
were done with GraphPad Prism.
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